Your shopping cart is currently empty

JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | JPM-OEt is a broad-spectrum cysteine cathepsin inhibitor with antitumor activity that binds covalently at the active site, irreversibly inhibiting the cysteine cathepsin family. |
| In vivo | JPM-OEt (50 mg/kg; i.p.; daily for 30 days) significantly decreases tumor cathepsin B activity[1]. JPM-OEt (50 mg/kg; i.p.; twice daily for 4 weeks) induces tumor regression in the RIP1-Tag2 (RT2) mouse model of pancreatic islet cell tumorigenesis[2]. JPM-OEt (50 mg/kg; i.p.; daily from 63 to 98 days) significantly delays tumor burden increase during the first 2 weeks of treatment[3]. |
| Molecular Weight | 392.45 |
| Formula | C20H28N2O6 |
| Cas No. | 262381-84-0 |
| Smiles | CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCc1ccc(O)cc1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.